Curaleaf Holdings, Inc. (OTCMKTS:CURLF - Get Free Report)'s share price was down 0.5% during mid-day trading on Thursday . The stock traded as low as $1.33 and last traded at $1.37. Approximately 340,191 shares changed hands during trading, a decline of 48% from the average daily volume of 659,549 shares. The stock had previously closed at $1.38.
Wall Street Analysts Forecast Growth
CURLF has been the subject of a number of research reports. Roth Capital upgraded shares of Curaleaf to a "strong-buy" rating in a research report on Sunday, November 10th. Cormark lowered Curaleaf from a "moderate buy" rating to a "hold" rating in a research report on Thursday, November 7th.
Read Our Latest Research Report on Curaleaf
Curaleaf Stock Up 10.2 %
The company has a debt-to-equity ratio of 0.85, a quick ratio of 0.51 and a current ratio of 1.11. The company has a fifty day moving average of $1.72 and a two-hundred day moving average of $2.74. The company has a market cap of $981.33 million, a PE ratio of -5.21 and a beta of 0.64.
Curaleaf Company Profile
(
Get Free Report)
Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Curaleaf, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Curaleaf wasn't on the list.
While Curaleaf currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
